Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 708

1.

Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.

Swanson EL, Indelicato DJ, Louis D, Flampouri S, Li Z, Morris CG, Paryani N, Slopsema R.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1549-57. doi: 10.1016/j.ijrobp.2011.10.014. Epub 2012 Jan 21.

PMID:
22270176
2.

Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.

Nichols RC Jr, Huh SN, Prado KL, Yi BY, Sharma NK, Ho MW, Hoppe BS, Mendenhall NP, Li Z, Regine WF.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):158-63. doi: 10.1016/j.ijrobp.2011.05.045. Epub 2012 Jan 13.

PMID:
22245197
3.

Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.

Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):752-9.

PMID:
15183478
4.

A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.

Weber DC, Trofimov AV, Delaney TF, Bortfeld T.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1596-606.

PMID:
15050341
5.

Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.

Weber DC, Bogner J, Verwey J, Georg D, Dieckmann K, Escudé L, Caro M, Pötter R, Goitein G, Lomax AJ, Miralbell R.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):373-84.

PMID:
16168832
6.

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD, Smith AR.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):362-72.

PMID:
16168831
7.

Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.

Trofimov A, Nguyen PL, Coen JJ, Doppke KP, Schneider RJ, Adams JA, Bortfeld TR, Zietman AL, Delaney TF, Shipley WU.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):444-53. Epub 2007 May 21.

8.

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.

Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):260-7. doi: 10.1016/j.ijrobp.2011.06.1959. Epub 2011 Oct 17.

PMID:
22014950
9.

Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.

Boehling NS, Grosshans DR, Bluett JB, Palmer MT, Song X, Amos RA, Sahoo N, Meyer JJ, Mahajan A, Woo SY.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):643-52. doi: 10.1016/j.ijrobp.2010.11.027. Epub 2011 Jan 27.

PMID:
21277111
10.

Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.

Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. doi: 10.1016/j.ijrobp.2008.12.048. Epub 2009 Apr 20.

PMID:
19386423
12.

Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.

Hattangadi JA, Rombi B, Yock TI, Broussard G, Friedmann AM, Huang M, Chen YL, Lu HM, Kooy H, MacDonald SM.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):1015-22. doi: 10.1016/j.ijrobp.2011.08.035. Epub 2011 Dec 3.

PMID:
22138463
13.

Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.

Kuo YC, Chiu YM, Shih WP, Yu HW, Chen CW, Wong PF, Lin WC, Hwang JJ.

Radiat Oncol. 2011 Jun 21;6:76. doi: 10.1186/1748-717X-6-76.

14.

Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.

Chera BS, Vargas C, Morris CG, Louis D, Flampouri S, Yeung D, Duvvuri S, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):994-1002. doi: 10.1016/j.ijrobp.2009.01.044. Epub 2009 Jul 18.

PMID:
19619961
16.

Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer.

Song WY, Huh SN, Liang Y, White G, Nichols RC, Watkins WT, Mundt AJ, Mell LK.

J Appl Clin Med Phys. 2010 Aug 15;11(4):3255.

PMID:
21081882
17.

Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.

Nicolini G, Ghosh-Laskar S, Shrivastava SK, Banerjee S, Chaudhary S, Agarwal JP, Munshi A, Clivio A, Fogliata A, Mancosu P, Vanetti E, Cozzi L.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):553-60. doi: 10.1016/j.ijrobp.2011.12.041. Epub 2012 Mar 2.

PMID:
22386376
18.
19.

Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.

Eccles CL, Bissonnette JP, Craig T, Taremi M, Wu X, Dawson LA.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):582-8. doi: 10.1016/j.ijrobp.2008.06.1496.

PMID:
18793961
20.

Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.

Koeck J, Abo-Madyan Y, Lohr F, Stieler F, Kriz J, Mueller RP, Wenz F, Eich HT.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):268-76. doi: 10.1016/j.ijrobp.2011.05.054. Epub 2011 Nov 11.

PMID:
22079733
Items per page

Supplemental Content

Write to the Help Desk